| 摘要 |
The invention concerns means for early detection of inflammatory autoimmune pathologies, characterised in that they are based on the qualitative and quantitative measurement of the anti-NO-protein (or peptide, or amino acid) or anti-fatty acid antibodies, as they have developed during the illness.
|
